• aquent

AQUENT Named Proven Performer By Managed Service Provider Zero Chaos

Boston, MA,(PR.com) – Aquent, the leading global staffing solutions firm dedicated to marketing, creative, and digital professionals, is proud to announce that the company was just recognized by the global contingent workforce solutions company ZeroChaos as a Proven Performer. This marks Aquent’s 5th premier partnership recognition from a managed service provider this year. ZeroChaos helps organizations achieve greater management and financial control of their workforce and talent supply chains. The company’s Proven Performers designation recognizes suppliers like Aquent who perform at superior [...]

By |2017-12-18T21:39:51+00:00September 1st, 2016|News|0 Comments

Medtouch Ranked As Fastest-Growing Company On INC. 5000

Inc. magazine named MedTouch to the 35th annual Inc. 5000 list, the most prestigious ranking of the nation’s fastest-growing private companies. MedTouch, the online strategy and technology partner for the best brands in healthcare, has earned the significant distinction of receiving the Inc. 5000 award for four consecutive years. MedTouch delivers strategic and technical expertise to healthcare organizations across the nation, including enterprise content management system (CMS) solutions, integrated digital strategy, UX + responsive design, service line marketing, content services, content marketing, and search + analytics. In the [...]

By |2017-12-18T21:44:04+00:00August 17th, 2016|News|0 Comments
  • Dynasil

Dynasil Corporation Of America (NASDAQ:DYSL) Is Pleased To Announce Our New Website Is Now Available At WWW.DYNASIL.COM

NEWTON, Mass.  — Dynasil Corporation of America (NASDAQ:DYSL) is pleased to announce our new website is now available at www.dynasil.com. We designed the new website to provide a better user experience with clear navigation and functionality throughout, while giving visitors easy access to company and investor information.  Visitors can learn about the leadership team and history of the Dynasil companies in the new, expanded “About” section.  Customers and investors can now understand Dynasil’s complete portfolio of radiation detection and photonics solutions by checking [...]

By |2017-12-18T21:43:10+00:00June 30th, 2016|News|0 Comments

ACT Government Leads In Waste Innovation

CANBERRA IS SET TO TRIAL SMART BINS TO TACKLE WASTE Canberra, ACT –  In an Australian Capital Territory first, the ACT Government will deploy Bigbelly Solar Powered rubbish bins across three new Canberra locations. The smart bins, which hold more than 4 times the amount of have been deployed as part of a 12 month trial to gather data for the ACT Government’s Waste Feasibility Study. The appropriately named Bigbelly® bins use the sun’s energy to power an internal compactor that compacts [...]

By |2017-12-18T21:40:50+00:00June 2nd, 2016|News|0 Comments

Best Practices For Pharmaceutical Waste

As more and more pharmaceutical companies launch into new projects, an even greater amount of pharmaceuticals are secreted into the environment. “Sustainability” has become commonplace in operational discussions; however, companies are still working toward that end. According to statistics reported by WHO, 15 percent of waste generated by health-care activities is considered to be hazardous: infectious, toxic, or radioactive. Washington State’s Department of Ecology explains the process of direct disposal of these pharmaceuticals: If disposed of or excreted to the sewer, pharmaceuticals are sent to [...]

By |2017-12-18T21:47:53+00:00May 24th, 2016|News|0 Comments
  • Organogenesis

New Research Highlights Ability Of PURAPLY™ AND PURAPLY Antimicrobial (AM)™ To Manage BIOBURDEN And Support Healing Across Variety Of Wound Types

Canton, Mass. – Three new research abstracts presented at the recent 2016 Symposium on Advanced Wound Care (SAWC) highlight the role of PuraPly™ and PuraPly Antimicrobial (AM)™ – two new FDA-cleared collagen matrix products from Organogenesis Inc. – in managing bioburden and supporting wound healing across a variety of wound types. The first study, one of the SAWC/WHS spring oral abstract winners, was presented by researchers from the University of Miami Miller School of Medicine. This study used a porcine wound model to [...]

By |2017-12-18T21:49:04+00:00May 18th, 2016|News|0 Comments

Robust New Features Give Capital Market Customers s Time Advantage, Enabling Them To Immediately Identify Trading Anomalies Typically Missed With Traditional Displays

BEDFORD, Mass.  – Datawatch Corporation (NASDAQ-CM: DWCH) today announced the general availability of Datawatch Panopticon 13.7, providing faster visual data analysis for trading, risk and compliance markets. The new powerful features enable buy-side and sell-side firms, and exchanges to perform big data analysis of e-trading data both in real-time as well as intra-day and historically to gain insights that speed decision making. Regulatory demands in the U.S. and Europe have made order transparency essential. However, the fragmentation of liquidity, increased data volumes and the [...]

By |2017-11-02T17:46:37+00:00May 16th, 2016|News|0 Comments

CYBEX Receives Presidential Award For Export Successes Latest Brunswick Acquisition Cited For Contributions To U.S. Export

Rosemont, IL — U.S. Secretary of Commerce Penny Pritzker today presented Cybex International with the President’s “E” Star Award for Exports at a ceremony in Washington, DC. The President’s “E” Award is the highest recognition any U.S. entity can receive for making a significant contribution to the expansion of U.S. exports. “Cybex International has demonstrated a sustained commitment to export expansion. The “E” Awards Committee was very impressed with Cybex International’s customization of its products for export markets,” said Secretary Pritzker [...]

By |2017-12-18T21:50:26+00:00May 16th, 2016|News|0 Comments
  • Organogenesis

Award-Winning Research From The Universality Of Miami Evaluates APLIGRAF’S®Role In Reversing a Chronic Wound Environment

Canton, Mass. – Award-winning research from a multidisciplinary team at the University of Miami provides new insight on what happens to a patient’s genomic profile when Apligraf®, an FDA-approved, bioengineered living cell-based therapy from Organogenesis Inc., is applied to a chronic venous leg ulcer (VLU), when compared to conventional therapy alone. The analysis found that Apligraf altered specific molecular and cellular responses in the wound environment, reversing the chronic wound profile to resemble more of an acute wound profile. “This [...]

By |2017-12-18T21:49:50+00:00May 11th, 2016|News|0 Comments
Go to Top